Drug · DIN 02557258
ZOPICLONE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since April 28, 2025.
- Drug Identification Number (DIN)
- 02557258
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Zopiclone N05CF01
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZOPICLONE | 7.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 28, 2025: NOC 35256Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named ZOPICLONE
- DIN 02282445 · Marketed
- DIN 02344122 · Marketed
- DIN 02385821 · Marketed
- DIN 02385848 · Marketed
- DIN 02321521 · Cancelled Post Market
- DIN 02321548 · Cancelled Post Market
- DIN 02344580 · Cancelled Pre Market
- DIN 02344599 · Cancelled Pre Market
- DIN 02403110 · Approved
- DIN 02403129 · Approved
- DIN 02405431 · Cancelled Pre Market
- DIN 02405458 · Cancelled Pre Market
- DIN 02557223 · Approved
- DIN 02557231 · Approved